A comparative analysis of IDH-mutant glioma in pediatric, young adult, and older adult patients.
Mary Jane Lim-FatJennifer A CotterMehdi TouatJayne VogelzangCecilia SousaWill PisanoJack GeduldigVarun BhaveJoseph DriverPei-Chi KaoAlana McGovernClement MaAshley S MargolKristina ColeAmy SmithStewart GoldmanKristiyana KanevaAi Lien TruongKellie J NazemiMatthew D WoodKaren D WrightWendy B LondonKatherine E WarrenPatrick Y WenWenya Linda BiSanda AlexandrescuDavid A ReardonKeith L LigonKee Kiat YeoPublished in: Neuro-oncology (2024)
IDH-mutant glioma YA patients had significantly shorter PFS and time to MT but did not differ in OS compared to pediatric and adult groups. Treatment approach varied significantly by patient age and warrant further study as addressable age-associated outcome drivers.